Drug development deals become more complex and intriguing by the month as University College London Business (UCLB) and Apollo Therapeutics […]
The AAVCOVID vaccine program at Massachusetts Eye and Ear and Massachusetts General Hospital, member of Mass General Bingham, has entered into […]
With rapid growth of cell and gene therapy development comes shortages and bottlenecks the require specialized manufacturing capability associated with […]
Taysha Gene Therapies just emerged out of stealth mode with a $30 million seed round and a strategic partnership with UT […]
Paris-based Sofinnova Partners placed a bet in Milan-based Genespire, a gene-therapy company developing best-in-class therapies for patients affected by gene disease. The […]
Esteban Engel, a viral neuroengineering researcher with Princeton Neuroscience Institute and team have developed a system for switching on the […]
In a notable partnership, Switzerland-based Lonza inked a partnership with leading research institutes and academic medical centers including Stanford University […]
Nationwide Children’s Hospital (NCH), a global hub for advanced gene therapy discovery, has submitted a proposal to the Biomedical Advanced […]
In a compelling story of brotherly love, familial connection, and the power of entrepreneurial energies, a 28-year old Boston-based entrepreneur, […]
Prevail Therapeutics announced that the U.S. FDA has approved an Investigational New Drug (IND) application for its experimental gene therapy […]
